Therapeutic Drug Monitoring

Therapeutical drug monitoring is defined as the clinical laboratory measurement of a chemical parameter that will directly influence drug prescribing procedures after appropriate medical interpretation. TDM refers to maintaining blood drug or plasma concentrations within a targeted therapeutic range or window for the individualization of drug dosage. Drug Monitoring begins after the drug is first prescribed, and involves determining an initial dosage regimen appropriate for the clinical condition and patient characteristics like age, organ function, weight and concomitant drug therapy.

The global therapeutic drug monitoring market was valued USD 1.77 billion in 2015 and it will be expected to reach over USD 3.37 billion by 2024 and shows significant growth in CAGR over the last few years.

  •  Therapeutic range
  • Biomonitoring
  • Blood glucose monitoring

Related Conference of Therapeutic Drug Monitoring

September 14-15, 2026

22nd European Organic Chemistry Congress

Rome, Italy
September 21-22, 2026

16th International Chemistry Congress

Barcelona, Spain
November 23-24, 2026

15th World Congress on Biopolymers and Biomaterials

Paris, France
November 26-27, 2026

6th International Conference on Petrochemistry and Natural Gas

Amsterdam, Netherlands
January 18-19, 2027

9th Global Summit on Polymer Chemistry

Paris, France
January 28-29, 2027

4thInternational Conference on Drug Discovery and Development

Singapore City, Singapore
February 25-26, 2027

17th International Conference on Chemistry Meeting

Paris, France
June 24-25, 2027

16th World Congress on Chromatography

Paris, France

Therapeutic Drug Monitoring Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in